Head and Neck Cancer Therapy
Studies in the area of head and neck cancer therapy reported from Memorial Sloan-Kettering Cancer Center, Department of Radiation Oncology
Published in Clinical Oncology Week, March 15th, 2010
New research, 'Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy,' is the subject of a report. In this recently published article, scientists in the United States conducted a study "To report the results from a prospective study of a series of locoregionally advanced head-and-neck cancer patients treated with platinum-based chemotherapy and intensity-modulated radiotherapy and to discuss the findings of their pre-/mid-treatment [(18)F]-misonidazole ((18)F-FMISO) positron emission tomography (PET) scans. A total of 28 patients agreed to participate in this...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- American Academy of Ophthalmology
HRT and cataract risk; smoking and uveitis - American College of Radiology / American Roentgen Ray Society
Ownership/leasing of PET scanners by nonradiologists on the rise - Dana-Farber Cancer Institute
Delaying post-surgical radiation increases risk of breast cancer recurrence in older women - Elsevier Health Sciences
Dietary factors influence ovarian cancer survival rates - Helmholtz Association of German Research Centres
Scientists discover cause of destructive inflammations - International Association for the Study of Lung Cancer
Lung cancer research explores the effects of patient attitudes on patient outcomes - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
